Current status and evolving treatment for primary liver cancers

Current status and evolving treatment for primary liver cancers

We are pleased to welcome you to the text “Recent Advances in Primary Liver Cancers”. Within this volume is a comprehensive assessment of medical and surgical care for the challenging malignancies that are primary liver cancers. The state-of-the-art review of our field brings contributions from leading interventional radiologists, medical oncologists and hepatobiliary surgeons practicing at major centers throughout the world. Readers should gain from the discussion that spans staging to palliation, and all phases of therapy in between.

It is said that for cancer patients, “With a Plan, Comes Hope”. We wish that this work assists you to make plans for your patients, and thereby deliver hope!


Special credit is directed to our emeritus editor, Dr. Charles Balch, who conceived of this work, the authors who prepared the reviews, and our working editors at the publisher for their diligent assistance.

Andrew X. Zhu
Thomas A. Aloia

Andrew X. Zhu, MD, PhD

Massachusetts General Hospital, Division of Hematology-Oncology, Department of Medicine, Harvard Medical School, Boston, MA, USA.

Thomas A. Aloia, MD

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

doi: 10.21037/cco.2018.10.05

Conflicts of Interest: The authors have no conflicts of interest to declare.

Cite this article as: Zhu AX, Aloia TA. Current status and evolving treatment for primary liver cancers. Chin Clin Oncol 2018;7(5):47. doi: 10.21037/cco.2018.10.05